Researchers report a shift in PK toward high-risk cases as new treatments for corneal ectasia and Fuchs dystrophy reduce low-risk procedures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results